,"Author: Brennan, Fionula M.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 36 (Of the 102 documents considered for the h-Index, 36 have been cited at least 36 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,7749,734,667,1401,370,9520
2009,Invasive Potential of Human Rheumatoid Tenosynovial Cells Is in Part MT1-MMP Dependent,"Jain A., Miller M.-C., Troeberg L., Itoh Y., Brennan F., Nanchahal J.",3635023,Journal of Hand Surgery,34,7,0,0,0,0,0,0
2009,Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease,"Midwood K., Orend G., Brennan F., Foxwell B., Sacre S., Piccinini A.M., Inglis J., Trebaul A., Chan E., Drexler S., Sofat N., Kashiwagi M.",10788956,Nature Medicine,15,7,0,0,0,0,0,0
2009,"Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717","Sumariwalla P.F., Palmer C.D., Pickford L.B., Feldmann M., Foxwell B.M.J., Brennan F.M.",14620324,Rheumatology,48,1,0,0,0,0,1,1
2008,Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.,"Sacre S.M., Lo A., Gregory B., Simmonds R.E., Williams L., Feldmann M., Brennan F.M., Foxwell B.M.",15506606,"Journal of immunology (Baltimore, Md. : 1950)",181,11,0,0,0,0,1,1
2008,Evidence that cytokines play a role in rheumatoid arthritis,"Brennan F.M., McInnes I.B.",219738,Journal of Clinical Investigation,118,11,0,0,1,1,9,10
2008,Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function.,"Brennan F.M., Foey A., Beech J.T., Feldmann M., Smith N.M., Owen S., Li C., Amjadi P., Green P., Andersson A., Palfreeman A.C., Hillyer P.",14786362,Arthritis research & therapy,10,2,0,0,1,1,1,2
2008,Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis,"Andersson A.K., Feldmann M., Brennan F.M.",3009475,Scandinavian Journal of Immunology,68,1,0,0,1,1,3,4
2008,Rac mediates TNF-induced cytokine production via modulation of NF-?B,"Williams L.M., Lali F., Willetts K., Balague C., Godessart N., Brennan F., Feldmann M., Foxwell B.M.J.",1615890,Molecular Immunology,45,9,0,0,1,1,6,7
2008,Interleukin-10 regulates TNF-?-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism,"Brennan F.M., Green P., Amjadi P., Robertshaw H.J., Alvarez-Iglesias M., Takata M.",142980,European Journal of Immunology,38,4,0,0,0,0,0,0
2008,Recent developments in the immunobiology of rheumatoid arthritis,"Andersson A.K., Li C., Brennan F.M.",14786354,Arthritis Research and Therapy,10,2,0,0,1,1,4,5
2008,Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.,"Elliot M.J., Woody J.N., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katasikis P., Brennan F.M., Bijl H., Ghrayeb J.",43591,Arthritis and rheumatism,58,2,0,0,0,0,0,0
2007,Preparation of mononuclear cells from synovial tissue.,"Beech J.T., Brennan F.M.",15431894,Methods in molecular medicine,135, ,0,0,0,0,0,0
2007,Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue,"Sacre S.M., Drexler S.K., Andreakos E., Feldmann M., Brennan F.M., Foxwell B.M.J.",34967,Annals of the Rheumatic Diseases,66,3,0,0,3,3,2,5
2007,TCR?dim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues,"Zhang Z., Marelli-Berg F., Isomaki P., Russell A., Dazzi F., Vyse T.J., Brennan F.M., Cope A.P., Gorman C.L., Vermi A.-C., Monaco C., Foey A., Owen S., Amjadi P., Vallance A., McClinton C.",64971,Blood,109,10,0,0,6,6,0,6
2007,Update on cytokines in rheumatoid arthritis,"Brennan F., Beech J.",10408711,Current Opinion in Rheumatology,19,3,0,4,7,11,5,16
2007,Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages,"Williams L.M., Sarma U., Willets K., Smallie T., Brennan F., Foxwell B.M.J.",219258,Journal of Biological Chemistry,282,10,0,3,9,12,4,16
2007,The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis,"Sacre S.M., Andreakos E., Kiriakidis S., Amjadi P., Lundberg A., Giddins G., Feldmann M., Brennan F., Foxwell B.M.",29440,American Journal of Pathology,170,2,0,6,21,27,9,36
2007,Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis,"Edwards C.J., Feldmann M., Pittman D.D., Feldman J.L., Beech J., Shields K.M., Stover J.A., Trepicchio W.L., Larsen G., Foxwell B.M.J., Brennan F.M.",10761551,Molecular Medicine,13, 1-2,0,1,4,5,6,11
2006,The importance of T cell interactions with macrophages in rheumatoid cytokine production,"Brennan F.M., Foey A.D., Feldmann M.",0070217X,Current Topics in Microbiology and Immunology,305, ,1,5,3,8,2,11
2006,Targeting rheumatoid tenosynovial angiogenesis with cytokine inhibitors,"Jain A., Kiriakidis S., Brennan F., Sandison A., Paleolog E., Nanchahal J.",0009921X,Clinical Orthopaedics and Related Research,,446,0,0,1,1,4,5
2006,"Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production","Horwood N.J., Page T.H., McDaid J.P., Palmer C.D., Campbell J., Mahon T., Brennan F.M., Webster D., Foxwell B.M.J.",221767,Journal of Immunology,176,6,2,11,18,29,10,41
2005,Anti-TNF therapy: Where have we got to in 2005?,"Feldmann M., Brennan F.M., Foxwell B.M.J., Taylor P.C., Williams R.O., Maini R.N.",8968411,Journal of Autoimmunity,25, ,7,18,13,31,7,45
2005,Lung-marginated monocytes modulate pulmonary microvascular injury during early endotoxemia,"O'Dea K.P., Young A.J., Yamamoto H., Robotham J.L., Brennan F.M., Takata M.",1073449X,American Journal of Respiratory and Critical Care Medicine,172,9,2,2,4,6,1,9
2005,Planning your research training,"Cope A.P., Brennan F.M., Hill Gaston J.S., Haskard D.O.",14620324,Rheumatology,44,11,0,0,0,0,0,0
2005,Release of tumour necrosis factor ? (TNF?) by TNF? cleaving enzyme (TACE) in response to septic stimuli in vitro,"Robertshaw H.J., Brennan F.M.",70912,British Journal of Anaesthesia,94,2,5,2,1,3,5,13
2004,Discussion,"Brennan F., Oppenheim J., Mantovani A., Gordon S., Cerundolo V., Pollard J.W., Forni G., Harris A., Balkwill F., Richmond A.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,Discussion,"Oppenheim J., Balkwill F., Richmond A., Blankenstein T., Brennan F., Gordon S., Mantovani A., Strieter R.M., Cerundolo V., Forni G., Thun M.J.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,General discussion II,"Mantovani A., Thun M.J., Feldmann M., Gordon S., Strieter R.M., Forni G., D'Incalci M., Brennan F., Oppenheim J., Richmond A., Pollard J.W., Rollins B., Blankenstein T., Harris A., Ristimaki A.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,A novel mechanism for TNF-? regulation by p38 MAPK: Involvement of NF-?B with implications for therapy in rheumatoid arthritis,"Campbell J., Foxwell B.M.J., Ciesielski C.J., Hunt A.E., Horwood N.J., Beech J.T., Hayes L.A., Denys A., Feldmann M., Brennan F.M.",221767,Journal of Immunology,173,11,14,12,9,21,4,39
2004,Discussion,"Pollard J.W., Feldmann M., Balkwill F., Gordon S., Caux C., Strieter R.M., Brennan F., Cerundolo V., Pepper M.S., Gallimore A., Blankenstein T., Oppenheim J.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,Anti-TNF? therapy of rheumatoid arthritis: What can we learn about chronic disease?,"Feldmann M., Brennan F.M., Paleolog E., Cope A., Taylor P., Williams R., Woody J., Maini R.N.",15282511,Novartis Foundation Symposium,256, ,20,3,2,5,0,25
2004,Discussion,"Balkwill F., Oppenheim J., Forni G., Ristimaki A., Richmond A., Caux C., D'Incalci M., Hermans I., Rollins B., Blankenstein T., Gordon S., Pollard J.W., Wilkins A., Strieter R.M., Brennan F., Mantovani A.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,Discussion,"Feldmann M., Richmond A., Ristimaki A., Balkwill F., Pepper M.S., Brennan F., Mantovani A., Strieter R.M.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,Discussion,"Thun M.J., Feldmann M., Ristimaki A., Brennan F., Smyth J., Balkwill F., Oppenheim J., Blankenstein T.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,General discussion I,"Smyth J., Pollard J.W., Balkwill F., Brennan F., Rollins B., Harris A., Richmond A., Oppenheim J., Feldmann M., Ristimaki A., Pepper M.S., Strieter R.M.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,Discussion,"Oppenheim J., Gallimore A., Brennan F., Blankenstein T., Gordon S., Mantovani A., Hermans I., Caux C., Richmond A.",15282511,Novartis Foundation Symposium,256, ,0,0,0,0,0,0
2004,IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis,"Lindsay J.O., Sandison A., Cohen P., Brennan F.M., Hodgson H.J.F.",1632116,Digestive Diseases and Sciences,49, 7-8,3,2,7,9,1,13
2004,Conventional protein kinase C and atypical protein kinase C? differentially regulate macrophage production of tumour necrosis factor-? and interleukin-10,"Foey A.D., Brennan F.M.",192805,Immunology,112,1,11,3,0,3,4,18
2004,"Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S) -thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-?-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid Arthritis","Zhang Y., Vansell N., Nickerson-Nutter C., Barone D., Mohler K., Black R., Skotnicki J., Gibbons J., Feldmann M., Frost P., Larsen G., Xu J., Lin L.-L., Levin J., Hegen M., Li G., Robertshaw H., Brennan F., Cummons T., Clarke D.",223565,Journal of Pharmacology and Experimental Therapeutics,309,1,28,11,4,15,5,48
2004,The transfer of a laboratory based hypothesis to a clinically useful therapy: The development of anti-TNF therapy of rheumatoid arthritis,"Feldmann M., Brennan F.M., Williams R.O., Woody J.N., Maini R.N.",15216942,Best Practice and Research: Clinical Rheumatology,18,1,15,5,6,11,3,29
2003,Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.,"Foey A.D., Field S., Ahmed S., Jain A., Feldmann M., Brennan F.M., Williams R.",14786362,Arthritis research & therapy,5,6,9,9,3,12,4,25
2003,Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents,"Foxwell B., Andreakos E., Brennan F., Feldmann M., Smith C., Conron M.",34967,Annals of the Rheumatic Diseases,62,2,7,0,2,2,0,9
2003,Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo,"Yoshimura S., Bondeson J., Brennan F.M., Foxwell B.M.J., Feldmann M.",3009475,Scandinavian Journal of Immunology,58,2,8,2,0,2,1,11
2003,Heterogeneous requirement of I?B kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: Implications for therapy,"Andreakos E., Smith C., Kiriakidis S., Monaco C., De Martin R., Brennan F.M., Paleolog E., Feldmann M., Foxwell B.M.",43591,Arthritis and Rheumatism,48,7,29,11,2,13,0,42
2003,Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis,"Lindsay J.O., Ciesielski C.J., Scheinin T., Brennan F.M., Hodgson H.J.",175749,Gut,52,7,14,3,3,6,0,20
2003,Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor ? production,"Horwood N.J., Mahon T., McDaid J.P., Campbell J., Mano H., Brennan F.M., Webster D., Foxwell B.M.J.",221007,Journal of Experimental Medicine,197,12,34,6,19,25,9,68
2003,Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-?B,"Calder V.L., Bondeson J., Brennan F.M., Foxwell B.M.J., Feldmann M.",3009475,Scandinavian Journal of Immunology,57,3,10,3,1,4,0,14
2003,Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis,"Lindsay J.O., Ciesielski C.J., Scheinin T., Brennan F.M., Hodgson H.J.",175749,Gut,52,3,24,2,2,4,1,29
2003,I?B kinase 2 but not NF-?B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction,"Andreakos E., Smith C., Monaco C., Brennan F.M., Foxwell B.M., Feldmann M.",64971,Blood,101,3,27,2,1,3,1,31
2002,IL-10 gene therapy prevents TNBS-included colitis,"Lindsay J., van Montfrans C., Brennan F., van Deventer S., Drillenburg P., Hodgson H., te Velde A., Sol Rodriguez Pena M.",9697128,Gene Therapy,9,24,20,2,5,7,1,28
2002,High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets.,"Horwood N.J., Smith C., Andreakos E., Quattrocchi E., Brennan F.M., Feldmann M., Foxwell B.M.",14659905,Arthritis research,4, ,6,0,0,0,0,6
2002,Treatment of rheumatoid tenosynovitis with cytokine inhibitors,"Jain A., Brennan F., Nanchahal J.",1406736,Lancet,360,9345,3,1,2,3,2,8
2002,The role of matrix metalloproteinases in rheumatoid tendon disease,"Jain A., Brennan F., Troeberg L., Nanchahal J.",3635023,Journal of Hand Surgery,27,6,5,1,3,4,1,10
2002,Is NF-?B a useful therapeutic target in rheumatoid arthritis?,"Feldmann M., Lundberg A., Paleolog E., Horwood N.J., Brennan F.M., Foxwell B.M.J., Andreakos E., Smith C., Bondeson J., Yoshimura S., Kiriakidis S., Monaco C., Gasparini C., Sacre S.",34967,Annals of the Rheumatic Diseases,61,2,30,5,6,11,1,42
2002,Cytokines and anti-cytokine biologicals in autoimmunity: Present and future,"Andreakos E.T., Foxwell B.M., Brennan F.M., Maini R.N., Feldmann M.",13596101,Cytokine and Growth Factor Reviews,13, 4-5,49,8,11,19,10,78
2002,Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: Involvement of phosphatidylinositol 3-kinase and nuclear factor ?B pathways in tumor necrosis factor ? production in rheumatoid arthritis,"Brennan F.M., Hayes A.L., Ciesielski C.J., Green P., Foxwell B.M.J., Feldmann M.",43591,Arthritis and Rheumatism,46,1,44,12,18,30,3,77
2002,Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: Implications for rheumatoid arthritis,"Foey A., Green P., Foxwell B., Feldmann M., Brennan F.",14659905,Arthritis Research,4,1,16,1,1,2,2,20
2001,The role of TNF alpha and IL-1 in rheumatoid arthritis.,"Feldmann M., Brennan F.M., Foxwell B.M., Maini R.N.",14222132,Current directions in autoimmunity,3, ,42,9,8,17,8,67
2001,Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities,"Feldmann M., Brennan F., Bondeson J., Paleolog E., Foxwell B., Maini R.",411345,Transplantation Proceedings,33,3,1,1,0,1,0,2
2001,CD40 ligation induces macrophage IL-10 and TNF-? production: Differential use of the PI3K and p42/44 MAPK-pathways,"Foey A.D., Feldmann M., Brennan F.M.",10434666,Cytokine,16,4,16,3,0,3,1,20
2001,NF-?B-inducing kinase is dispensable for activation of NF-?B in inflammatory settings but essential for lymphotoxin ? receptor activation of NF-?B in primary human fibroblasts,"Smith C., Andreakos E., Crawley J.B., Brennan F.M., Feldmann M., Foxwell B.M.J.",221767,Journal of Immunology,167,10,34,8,7,15,2,51
2001,High efficiency gene transfer is an efficient way of defining therapeutic targets: A functional genomics approach,"Foxwell B.M.J., Yoshimura S., Bondeson J., Brennan F.M., Feldmann M.",34967,Annals of the Rheumatic Diseases,60,3,3,0,1,1,0,4
2001,Cytokine blockade in rheumatoid arthritis,"Feldmann M., Maini R.N., Bondeson J., Taylor P., Foxwell B.M.J., Brennan F.M.",652598,Advances in Experimental Medicine and Biology,490, ,19,4,2,6,0,25
2001,"Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis","Jain A., Nanchahal J., Troeberg L., Green P., Brennan F.",43591,Arthritis and Rheumatism,44,8,19,8,4,12,3,34
2001,"A follow-up to ""anti-cytokine therapy in chronic destructive arthritis"" by Wim B van den Berg",Brennan F.M.,14659905,Arthritis Research,3,4,4,0,1,1,0,5
2001,Role of NF?B in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI,"Yoshimura S., Bondeson J., Brennan F.M., Foxwell B.M.J., Feldmann M.",142980,European Journal of Immunology,31,6,57,6,2,8,0,65
2001,The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10,"Lindsay J.O., Ciesielski C.J., Scheinin T., Hodgson H.J., Brennan F.M.",221767,Journal of Immunology,166,12,31,1,4,5,0,36
2001,"Effective antigen presentation by dendritic cells is NF-?B dependent: Coordinate regulation of MHC, co-stimulatory molecules and cytokines","Yoshimura S., Bondeson J., Foxwell B.M.J., Brennan F.M., Feldmann M.",9538178,International Immunology,13,5,69,17,9,26,2,97
2000,Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.,"Maini R.N., Taylor P.C., Paleolog E., Charles P., Ballara S., Brennan F.M., Feldmann M.",9114300,"Nihon Rinsho Men""eki Gakkai kaishi = Japanese journal of clinical immunology",23,6,2,0,0,0,0,2
2000,Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: Evidence for heterogenecity in the requirement for NF?B in tumour necrosis factor production,"Foxwell B.M.J., Bondeson J., Brennan F., Feldmann M.",34967,Annals of the Rheumatic Diseases,59,1,5,1,1,2,0,7
2000,Future prospects for anti-cytokine treatment,"Feldmann M., Miotla J., Paleolog E., Williams R., Malfait A.-M., Taylor P., Brennan F.-M., Maini R.N.",34967,Annals of the Rheumatic Diseases,59,1,9,1,2,3,1,13
2000,Route of monocyte differentiation determines their cytokine production profile: CD40 ligation induces interleukin 10 expression,"Foey A.D., Feldmann M., Brennan F.M.",10434666,Cytokine,12,10,12,1,1,2,0,14
2000,TNF is here to stay!,"Balkwill F., Foxwell B., Brennan F.",1675699,Immunology Today,21,10,9,1,0,1,0,10
2000,Effective adenoviral transfer of I?B? into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-?B dependent,"Bondeson J., Brennan F., Foxwell B., Feldmann M.",0315162X,Journal of Rheumatology,27,9,38,7,0,7,0,45
2000,Interleukin 10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway,"Williams L., Lali F., Clarke C., Brennan F., Foxwell B.",10434666,Cytokine,12,7,5,0,0,0,0,5
1999,Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis,"Maini R.N., Taylor P.C., Paleolog E., Charles P., Ballara S., Brennan F.M., Feldmann M.",34967,Annals of the Rheumatic Diseases,58,1,36,5,5,10,1,47
1999,The rationale for the current boom in anti-TNF? treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNF? and minimise hazards?,"Feldmann M., Bondeson J., Brennan F.M., Foxwell B.M.J., Maini R.N.",34967,Annals of the Rheumatic Diseases,58,1,14,3,2,5,0,19
1999,CD45-induced tumor necrosis factor production in monocytes is phosphatidylinositol 3-kinase-dependent and nuclear factor-?B-independent,"Hayes A.L., Smith C., Foxwell B.M.J., Brennan F.M.",219258,Journal of Biological Chemistry,274,47,26,2,0,2,0,28
1999,Interleukin 10 and arthritis,Brennan F.M.,14620324,Rheumatology,38,4,10,3,2,5,1,16
1999,Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis,"Butler D.M., Malfait A.-M., Maini R.N., Brennan F.M., Feldmann M.",142980,European Journal of Immunology,29,7,44,5,5,10,0,54
1999,Defining therapeutic targets by using adenovirus: Blocking NF-?B inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators,"Bondeson J., Foxwell B., Brennan F., Feldmann M.",278424,Proceedings of the National Academy of Sciences of the United States of America,96,10,134,10,3,13,1,148
1999,"Selective regulation of cytokine induction by adenoviral gene transfer, of I?B? into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-?B independent","Bondeson J., Browne K.A., Brennan F.M., Foxwell B.M.J., Feldmann M.",221767,Journal of Immunology,162,5,110,6,8,14,0,124
1998,Anti-TNF? therapy is useful in rheumatoid arthritis and Crohn's disease: Analysis of the mechanism of action predicts utility in other diseases,"Feldman M., Taylor P., Paleolog E., Brennan F.M., Maini R.N.",411345,Transplantation Proceedings,30,8,65,1,2,3,1,69
1998,Cytokines in autoimmune disorders,"Feldmann M., Brennan F.M., Maini R.",8830185,International Reviews of Immunology,17, 1-4,52,5,9,14,8,74
1998,Role of pro-inflammatory cytokines in rheumatoid arthritis,"Brennan F.M., Maini R.N., Feldmann M.",3444325,Springer Seminars in Immunopathology,20, 1-2,70,4,4,8,6,84
1998,Cytokine therapy in rheumatoid arthritis,"Hermann J., Walmsley M., Brennan F.M.",3444325,Springer Seminars in Immunopathology,20, 1-2,4,1,0,1,1,6
1998,Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis,"Hermann J.A., Hall M.A., Maini R.N., Feldmann M., Brennan F.M.",43591,Arthritis and Rheumatism,41,8,60,3,7,10,2,72
1998,Efficient adenoviral infection with I?B? reveals that macrophage tumor necrosis factor ? production in rheumatoid arthritis is NF-?B dependent,"Foxwell B., Browne K., Bondeson J., Clarke C., De Martin R., Brennan F., Feldmann M.",278424,Proceedings of the National Academy of Sciences of the United States of America,95,14,133,20,11,31,3,167
1998,Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis,"Malfait A.M., Butler D.M., Presky D.H., Maini R.N., Brennan F.M., Feldmann M.",99104,Clinical and Experimental Immunology,111,2,57,9,4,13,5,75
1998,Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-?: Role of the p38 and p42/44 mitogen-activated protein kinases,"Foey A.D., Parry S.L., Williams L.M., Feldmann M., Foxwell B.M.J., Brennan F.M.",221767,Journal of Immunology,160,2,167,14,10,24,4,195
1997,"DBA/1 mice expressing the human TNF-? transgene develop a severe, erosive arthritis: Characterization of the cytokine cascade and cellular composition","Butler D.M., Malfait A.-M., Mason L.J., Warden P.J., Kollias G., Maini R.N., Feldmann M., Brennan F.M.",221767,Journal of Immunology,159,6,64,7,4,11,2,77
1997,Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action,"Feldmann M., Brennan F., Paleolog E., Taylor P., Maini R.N.",11485493,European Cytokine Network,8,3,21,0,1,1,0,22
1997,Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-? (cA2) therapy,"Brennan F.M., Browne K.A., Green P.A., Jaspar J.-M., Maini R.N., Feldmann M.",2637103,British Journal of Rheumatology,36,6,109,11,6,17,3,129
1997,TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis,"Maini R.N., Elliott M., Brennan F.M., Williams R.O., Feldmann M.",9034641,APMIS,105,4,35,2,1,3,0,38
1997,Contact with T Cells Modulates Monocyte IL-10 Production: Role of T Cell Membrane TNF-?,"Parry S.L., Sebbag M., Feldmann M., Brennan F.M.",221767,Journal of Immunology,158,8,61,5,2,7,2,70
1997,"Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-?, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis","Sebbag M., Parry S.L., Brennan F.M., Feldmann M., Sebbag M.",142980,European Journal of Immunology,27,3,83,7,9,16,3,102
1996,Cytokines in autoimmunity,"Brennan F.M., Feldmannt M.",9527915,Current Opinion in Immunology,8,6,72,2,4,6,3,81
1996,Transgenic models for arthritis: Useful clues to be gained?,Brennan F.M.,7853890,Annals of Medicine,28,4,1,0,0,0,0,1
1996,Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine,"Crawley J.B., Williams L.M., Mander T., Brennan F.M., Foxwell B.M.J.",219258,Journal of Biological Chemistry,271,27,47,4,1,5,1,53
1996,Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both P55 and P75 TNF receptor shedding and TNF? processing in RA synovial membrane cell cultures,"Williams L.M., Gibbons D.L., Gearing A., Maini R.N., Feldmann M., Brennan F.M.",219738,Journal of Clinical Investigation,97,12,92,4,2,6,2,100
1996,Role of cytokines in rheumatoid arthritis,"Feldmann M., Brennan F.M., Maini R.N.",7320582,Annual Review of Immunology,14, ,1051,107,106,213,65,1329
1996,Rheumatoid arthritis,"Feldmann M., Brennan F.M., Maini R.N.",928674,Cell,85,3,410,64,47,111,19,540
1995,TNF? is an effective therapeatic target for rheumatoid arthritis,"Feldmann M., Brennan F.M., Elliott M.J., Williams R.O., Maini R.N.",778923,Annals of the New York Academy of Sciences,766, ,42,5,1,6,0,48
1995,Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-? antibody with the interleukin-1 receptor antagonist,"Butler D.M., Maini R.N., Feldmann M., Brennan F.M.",11485493,European Cytokine Network,6,4,136,12,7,19,5,160
1995,Beneficial effects of tumour necrosis factor-alpha (TNF-?) blockade in rheumatoid arthritis (RA),"Maini R.N., Elliott M.J., Brennan F.M., Feldmann M.",99104,Clinical and Experimental Immunology,101,2,62,1,2,3,5,70
1995,TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: Evidence of feedback control of TNF action,"Brennan F.M., Gibbons D.L., Cope A.P., Katsikis P., Maini R.N., Feldman M.",3009475,Scandinavian Journal of Immunology,42,1,44,1,1,2,0,46
1995,Monoclonal anti-TNF? antibody as a probe of pathogenesis and therapy of rheumatoid disease,"Maini R.N., Elliott M.J., Brennan F.M., Williams R.O., Chu C.Q., Paleolog E., Charles P.J., Taylor P.C., Feldmann M.",1052896,Immunological Reviews,,144,121,4,2,6,2,129
1995,"Erratum: Beneficial effects of tumour necrosis factor-alpha (TNF-?) blockade in rheumatoid arthritis (RA) (Clin Exp Immunol 1995, 101:207-212)","Maini R.N., Elliott M.J., Brennan F.M., Feldmann M.",99104,Clinical and Experimental Immunology,102,2,0,0,0,0,0,0
1995,Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins,"Scallon B.J., Trinh H., Nedelman M., Brennan F.M., Feldmann M., Ghrayeb J.",10434666,Cytokine,7,8,28,3,0,3,0,31
1995,Soluble TNF receptor production by activated T lymphocytes: Differential effects of acute and chronic exposure to TNF,"Cope A.P., Aderka D., Wallach D., Kahan M., Chu N.R., Brennan F.M., Feldmann M.",192805,Immunology,84,1,46,2,1,3,1,50
1995,Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1? and IL-1 receptor antagonist,"Phillips W.G., Feldmann M., Breathnach S.M., Brennan F.M.",99104,Clinical and Experimental Immunology,101,1,17,0,0,0,0,17
1995,Cytokine expression in chronic inflammatory disease,"Brennan F.M., Maini R.N., Feldmann M.",71420,British Medical Bulletin,51,2,69,5,3,8,0,77
1994,TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells,"Butler D.M., Scallon B., Meager A., Kissonerghis M., Corcoran A., Chernajovsky Y., Feldmann M., Ghrayeb J., Brennan F.M.",10434666,Cytokine,6,6,16,0,0,0,0,16
1994,Targeting TNF? for the therapy of rheumatoid arthritis,"Maini R.N., Elliott M., Brennan F.M., Williams R.O., Feldmann M.",0392856X,Clinical and Experimental Rheumatology,12,11,16,0,1,1,0,17
1994,TNF? as a therapeutic target in rheumatoid arthritis,"Feldmann M., Brennan F.M., Elliott M., Katsikis P., Maini R.N.",926213,Circulatory Shock,43,4,31,2,1,3,1,35
1994,Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis,"Feldmann M., Elliott M.J., Brennan F.M., Maini R.N.",1978357,Journal of Interferon Research,14,5,5,0,0,0,0,5
1994,"Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes","Joyce D.A., Gibbons D.P., Green P., Steer J.H., Feldmann M., Brennan F.M.",142980,European Journal of Immunology,24,11,116,5,7,12,5,133
1994,Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines,"Gibbons D.L., Rowe M., Cope A.P., Feldmann M., Brennan F.M.",142980,European Journal of Immunology,24,8,39,0,1,1,0,40
1994,Immunoregulatory role of interleukin 10 in rheumatoid arthritis,"Katsikis P.D., Chu C.-Q., Brennan F.M., Maini R.N., Feldmann M.",221007,Journal of Experimental Medicine,179,5,310,13,16,29,7,346
1994,Role of cytokines in experimental arthritis,Brennan F.M.,99104,Clinical and Experimental Immunology,97,1,13,0,0,0,0,13
1994,From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target,"Feldmann M., Brennan F.M., Maini R.N.",11925612,Immunologist,2,5,7,0,0,0,0,7
1994,P55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts,"Butler D.M., Feldmann M., Di Padova F., Brennan F.M.",11485493,European Cytokine Network,5,5,26,4,0,4,1,31
1994,Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis,"Brennan F.M., Cope A.P., Katsikis P., Gibbons D.L., Maini R.N., Feldmann M.",10150145,Chemical Immunology,60, ,4,0,0,0,0,4
1994,Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis,"Cope A.P., Londei M., Chu N.R., Cohen S.B.A., Elliott M.J., Brennan F.M., Maini R.N., Feldmann M.",219738,Journal of Clinical Investigation,94,2,126,9,8,17,2,145
1993,Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor ?,"Elliott M.J., Ghrayeb J., Woody J.N., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katsikis P., Brennan F.M., Walker J., Bijl H.",43591,Arthritis and Rheumatism,36,12,566,27,26,53,10,629
1993,Differential regulation of tumor necrosis factor receptors (TNF-R) by IL-4; upregulation of p55 and p75 TNF-R on synovial joint mononuclear cells,"Cope A.P., Gibbons D.L., Aderka D., Foxwell B.M., Wallach D., Maini R.N., Feldmann M., Brennan F.M.",10434666,Cytokine,5,3,21,2,0,2,1,24
1993,The effects of tumor necrosis factor (TNF) derivatives on TNF receptors,"Tchorzewski H., Jarosz J., Parniewski P., Kocur E., Zeman K., Paleolog E., Brennan F., Feldmann M., Kahan M., Guga P., Kwinkowski M., Szymanska B.",10434666,Cytokine,5,2,20,0,1,1,1,22
1993,Localization of tumour necrosis factor-alpha (TNF-?) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor,"Kristensen M., Chu C.Q., Eedy D.J., Feldmann M., Brennan F.M., Breathnach S.M.",99104,Clinical and Experimental Immunology,94,2,56,11,7,18,4,78
1993,Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus,"Aderka D., Feldmann M., Wallach D., Wysenbeek A., Engelmann H., Cope A.P., Brennan F., Molad Y., Hornik V., Levo Y., Maini R.N.",43591,Arthritis and Rheumatism,36,8,107,1,4,5,2,114
1993,Cytokines and cytokine receptors: From cloning to the clinic Keystone Symposium on Molecular and Cellular Biology (1993),Brennan F.M.,9599673,International Journal of Experimental Pathology,74,6,2,0,0,0,0,2
1993,TNF-? in rheumatoid arthritis and prospects of anti-TNF therapy,"Maini R.N., Brennan F.M., Williams R., Chu C.Q., Cope A.P., Gibbons D., Elliott M., Feldmann M.",0392856X,Clinical and Experimental Rheumatology,11,8,35,2,2,4,0,39
1993,Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis,"Venn G., Nietfeld J.J., Duits A.J., Brennan F.M., Arner E., Covington M., Billingham M.E.J., Hardingham T.E.",43591,Arthritis and Rheumatism,36,6,41,3,2,5,1,47
1992,Cytokines in autoimmunity,"Brennan F.M., Feldmann M.",9527915,Current Opinion in Immunology,4,6,55,4,1,5,0,60
1992,Evaluation of the role of cytokines in autoimmune disease: The importance of TNF? in rheumatoid arthritis,"Feldmann M., Brennan F.M., Williams R.O., Cope A.P., Gibbons D.L., Katsikis P.D., Maini R.N.",13596101,Cytokine and Growth Factor Reviews,4,3,24,2,3,5,1,30
1992,Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases,"Cope A.P., Feldmann M., Aderka D., Doherty M., Engelmann H., Gibbons D., Jones A.C., Brennan F.M., Maini R.N., Wallach D.",43591,Arthritis and Rheumatism,35,10,185,5,6,11,3,199
1992,Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: Implications for local actions of tumor necrosis factor ?,"Deleuran B.W., Chu C.-Q., Field M., Brennan F.M., Mitchell T., Feldmann M., Maini R.N.",43591,Arthritis and Rheumatism,35,10,115,3,5,8,0,123
1992,"Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1? in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis","Kristensen M., Deleuran B., Eedy D.J., Feldmann M., Breathnach S.M., Brennan F.M.",70963,British Journal of Dermatology,127,4,34,2,1,3,1,38
1992,Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints,"Brennan F.M., Gibbons D.L., Mitchell T., Cope A.P., Maini R.N., Feldmann M.",142980,European Journal of Immunology,22,7,42,2,0,2,0,44
1992,Cytokine measurements in biological fluids,"Cope A.P., Brennan F.M.",2637103,British Journal of Rheumatology,31,11,3,0,0,0,0,3
1992,"Localization of interleukin-1?, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis","Deleuran B.W., Chu C.Q., Field M., Brennan F.M., Katsikis P., Feldmann M., Maini R.N.",2637103,British Journal of Rheumatology,31,12,101,2,4,6,0,107
1992,TNF? - A pivotal role in rheumatoid arthritis?,"Brennan F.M., Maini R.N., Feldmann M.",2637103,British Journal of Rheumatology,31,5,189,7,6,13,6,208
1991,Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-?,"Turner M., Chantry D., Katsikis P., Berger A., Brennan F.M., Feldmann M.",142980,European Journal of Immunology,21,7,70,3,1,4,1,75
1991,Cytokine assays: Role in evaluation of the pathogenesis of autoimmunity,"Feldmann M., Barrett K., Corcoran A., Kissonerghis M., Zheng R., Grubeck-Loebenstein B., Barkley D., Chu C.Q., Field M., Maini R.N., Brennan F.M., Chantry D., Haworth C., Turner M., Katsikis P., Londei M., Abney E., Buchan G.",1052896,Immunological Reviews,,119,28,2,1,3,1,32
1991,Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor-?,"Haworth C., Brennan F.M., Chantry D., Turner M., Maini R.N., Feldmann M.",142980,European Journal of Immunology,21,10,121,7,7,14,4,139
1991,Cytokine expression in rheumatoid arthritis.,"Brennan F.M., Field M., Chu C.Q., Feldmann M., Maini R.N.",2637103,British Journal of Rheumatology,30, ,58,4,2,6,1,65
1990,Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: Lack of effect on spontaneous cytokine production in joint cell cultures,"Brennan F.M., Chantry D., Turner M., Foxwell B., Maini R., Feldmann M.",99104,Clinical and Experimental Immunology,81,2,40,4,1,5,1,46
1990,Interleukin 7 and interleukin 4 stimulate human thymocyte growth through distinct mechanisms,"Varma C., Chantry D., Brennan F., Turner M., Katz F., Feldmann M.",10434666,Cytokine,2,1,2,0,0,0,0,2
1990,Cytokine production in the rheumatoid joint: Implications for treatment,"Feldmann M., Chu A., Field M., Maini R.N., Brennan F.M., Chantry D., Haworth C., Turner M., Abney E., Buchan G., Barrett K., Barkley D.",34967,Annals of the Rheumatic Diseases,49,1,68,3,1,4,1,73
1990,Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes,"Chantry D., Turner M., Brennan F., Kingsbury A., Feldmann M.",10434666,Cytokine,2,1,21,1,1,2,0,23
1990,CD5+B cells in rheumatoid arthritis and Sjogren's syndrome,"Maini R.N., Plater-Zyberk C., Brown C.M.S., Aghamohammadi S., Brennan F.M., Feldmann M.",0392856X,Clinical and Experimental Rheumatology,8,5,0,0,0,0,0,0
1990,Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells,"Brennan F.M., Zachariae C.O.C., Chantry D., Larsen C.G., Turner M., Maini R.N., Matsushima K., Feldmann M.",142980,European Journal of Immunology,20,9,99,3,3,6,0,105
1989,Rapid clearance of the lupus antigen Sm is delayed by autoantibody: A possible mechanism of autoimmunity perpetuation,"Field M., Nelsom R.D., Brennan F.M., Williams D.G., Schreiber L., McCarthy D.A., Maini R.N.",99104,Clinical and Experimental Immunology,78,3,1,0,0,0,0,1
1989,Cytokine production in culture by cells isolated from the synovial membrane,"Brennan F.M., Chantry D., Jackson A.M., Maini R.N., Feldmann M.",8968411,Journal of Autoimmunity,2,1,27,3,3,6,2,35
1989,'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome,"Plater-Zyberk C., Brennan F.M., Feldmann M., Maini R.N.",8968411,Journal of Autoimmunity,2,1,7,1,0,1,0,8
1989,Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis,"Londei M., Savill C.M., Verhoef A., Brennan F., Leech Z.A., Duance V., Maini R.N., Feldmann M.",278424,Proceedings of the National Academy of Sciences of the United States of America,86,2,91,5,4,9,2,102
1989,Coordinate expansion of 'fetal type' lymphocytes (TCR ??+T and CD5+B) in rheumatoid arthritis and primary Sjogren's syndrome,"Brennan F., Plater-Zybrek C., Maini R.N., Feldmann M.",99104,Clinical and Experimental Immunology,77,2,17,3,0,3,0,20
1989,Inhibitory effect of TNF? antibodies on synovial cell interleukin-1 production in rheumatoid arthritis,"Brennan F.M., Jackson A., Chantry D., Maini R., Feldmann M.",1406736,Lancet,2,8657,345,27,24,51,14,410
1988,Role of HLA class II and cytokine expression in rheumatoid arthritis,"Feldmann M., Maini R.N., Kissonerghis A.M., Buchan G., Brennan F., Turner M., Haworth C., Barrett K., Chantry D., Ziegler A.",3013847,"Scandinavian Journal of Rheumatology, Supplement",18,76,0,0,0,0,1,1
1988,T cells expressing ?? chain receptors in rheumatoid arthritis,"Brennan F.M., Londei M., Jackson A.M., Hercend T., Brenner M.B., Maini R.N., Feldmann M.",8968411,Journal of Autoimmunity,1,4,21,1,1,2,0,23
1988,Anti-nRNP anti-nuclear antibody-secreting cells are represented in the B-lymphocyte repertoire of normal and MRL/MP-lpr/lpr lupus mice,"Brennan F.M., Andrew E.M., Williams D.G., Maini R.N.",192805,Immunology,63,2,1,0,0,0,0,1
1988,Analysis of T cell clones in rheumatoid arthritis,"Feldmann M., Londei M., Leech Z., Brennan F., Savill C., Maini R.N.",3444325,Springer Seminars in Immunopathology,10, 2-3,2,0,0,0,0,2
1988,Heterogeneity of T cell receptor idiotypes in rheumatoid arthritis,"Brennan F.M., Allard S., Londei M., Savill C., Boylston A., Carrel S., Maini R.N., Feldmann M.",99104,Clinical and Experimental Immunology,73,3,7,0,0,0,0,7
1987,MRL-1pr/1pr mice show an impairment of IgG aggregate removal which relates to parameters of disease activity,"Field M., Brennan F.M., McCarthy 8et al. D.",192805,Immunology,61,4,0,0,0,0,0,0
1986,Administration of monoclonal anti-Sm antibody prolongs the survival and renal function of MRL-lpr/lpr mice,"Brennan F.M., Williams D.G., Bovill D.",99104,Clinical and Experimental Immunology,65,1,3,0,0,0,0,3
1986,Individual variation of anti-Sm autoantibodies in the MRL/MP-lpr/lpr mouse: Age-related increase in diversity,"Williams D.G., Brennan F.M., Stocks M.R., Maini R.N.",99104,Clinical and Experimental Immunology,65,3,3,0,0,0,0,3
1985,MRL mice show an age-related impairment of IgG aggregate removal from the circulation,"Field M., Brennan F.M., Melsom R.D.",99104,Clinical and Experimental Immunology,61,1,0,0,0,0,0,0
1984,Clearance and organ localization of particles and soluble complexes in mice with circulating complexes,"Carter S.D., Brennan F.M., Grace S.A., Elson C.J.",192805,Immunology,52,4,0,0,0,0,0,0
1983,Preparation of covalent IgG complexes of defined size and their clearance from the circulation of mice,"Brennan F.M., Grace S.A., Elson C.J.",221759,Journal of Immunological Methods,56,2,1,0,0,0,0,1
1982,Clearance and localization of immunoglobulin oligomers in mice with chronic circulating endogenous complexes,"Grace S.A., Brennan F.M.",192805,Immunology,47,2,0,0,0,0,0,0
